BioSpace News Archive

Swing Therapeutics, a digital therapeutics company developing evidence-backed treatments for autoimmune and chronic pain conditions, today announced that it has closed a $10.3M Series A funding round.

In 2021 the Company initiated a series of cancer screening studies aimed at uncovering therapeutic opportunities for cepharanthine when used alone or in combination with standard of care (SoC) chemotherapy drugs.

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) (“ScreenPro” or the “Company”) reports that the Covid-19 testing administered remained steady in May with approximately 23,000 tests.

Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells in vivo to treat patients with solid and hematologic malignancies, announced today that it will have a poster presentation at the 2022 International Society for Stem Cell Research (ISSCR) Annual Meeting, to be held June 15-18, 2022 in San Francisco, California.

PepGen Inc. (“PepGen”), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today reported financial results for the first quarter ended March 31, 2022.

Preliminary results of first cohort in the first-in-human Phase 1a allows Company to proceed to 16 mg/kg dose of WP1122 in second cohort toward establishing maximum tolerated dose (MTD).

OSE Immunotherapeutics SA announces that the Company is one of the first biotech startup companies selected by Microsoft France to be a privileged partner of its support program for French Biotech & Deeptech Startups.

Vicore Pharma Holding AB announces initiation of a first-in-human trial with the novel ATRAG C106.

Nykode Therapeutics ASA announced that it has been uplisted to the main list of the Oslo Stock Exchange with first day of trading today, June 16, 2022.

Biophytis SA announced that it is presenting new preclinical efficacy data for its product Sarconeos in SMA at the SMA Cure 2022 conference in Anaheim, California, USA on June 16-19, 2022.